PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy
PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy
Recruiting · NCT03647072 · Registry updated 2018-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 3 | 2018-08-27 | NCT03647072 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sherief Abd-Elsalam | 21 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sherief Abd-Elsalam | Cairo | Egypt | 4 |